United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022
Breast cancer is one of the major cause of mortality among women in both the developed and developing world. Early detection remains the primary defense available to patients in preventing the development of life-threatening breast cancer.
Breast cancer is one of the major cause of mortality among women in both the developed and developing world. Early detection remains the primary defense available to patients in preventing the development of life-threatening breast cancer.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Global <strong>United</strong> <strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> Trends,<br />
Analys<strong>is</strong>, And Forecast To 2025<br />
<strong>Breast</strong> cancer <strong>is</strong> one of the major cause of mortality among women in both the developed and developing world. Early<br />
detection remains the primary defense available <strong>to</strong> patients in preventing the development of life-threatening breast<br />
cancer.<br />
Long–term Growth Projection:<br />
Mammography grasp the dominant share in the <strong>United</strong> <strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong><br />
<strong>Breast</strong> MRI <strong>Screening</strong> market <strong>is</strong> likely <strong>to</strong> <strong>reach</strong> <strong>more</strong> <strong>than</strong> <strong>US$</strong> 350 Million <strong>by</strong> <strong>2022</strong><br />
Number of mammograpy screening population in <strong>United</strong> <strong>States</strong> will increase <strong>to</strong> <strong>more</strong> <strong>than</strong> 50<br />
Million <strong>by</strong> <strong>2022</strong><br />
<strong>Market</strong> growth can be attributed <strong>to</strong> fac<strong>to</strong>rs such as increasing incidence of breast cancer, increasing awareness related<br />
<strong>to</strong> early breast cancer detection, growing government investments and funding for breast cancer screening,<br />
technological advancement in breast imaging technologies and implementation of several initiatives <strong>to</strong> create<br />
awareness about the early detection of breast cancer.<br />
“<strong>United</strong> <strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> Analys<strong>is</strong>: By Type, Share, Cases, Clinical Trials Insight, Reimbursement,<br />
Competitive Strategies and Forecast, 2017 - <strong>2022</strong>” provides a deep and thorough evaluation of the <strong>United</strong> <strong>States</strong> <strong>Breast</strong><br />
<strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong>. The report provides an in–depth analys<strong>is</strong> of the breast cancer invasive, in situ and men cases<br />
and added breast cancer death figures of both men and women in <strong>United</strong> <strong>States</strong>. Further<strong>more</strong>, the report also covered<br />
mammography screening population from 2010 <strong>to</strong> <strong>2022</strong>.<br />
Get Sample report @: https://www.futuregenicreports.com/Request-Sample/100277<br />
<strong>Market</strong> outlook in value terms has been analyzed based on h<strong>is</strong><strong>to</strong>rical, current and potential trends and the market <strong>is</strong><br />
projected from 2017 <strong>to</strong> <strong>2022</strong>. The breast cancer screening market <strong>is</strong> segmented based on its product types:<br />
Mammography, <strong>Breast</strong> MRI and <strong>Breast</strong> Ultrasound. Additionally, the report includes assessment of clinical trials and<br />
reimbursement pattern. The report also explores detailed description of growth drivers and inhibi<strong>to</strong>rs of the <strong>United</strong><br />
<strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong>.<br />
The report concludes with the profiles of major manufacturers of Mammography, MRI and Ultrasound such as Hologic,<br />
Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE<br />
Healthcare. The major manufacturers are evaluated on various parameters such as business overview, marketed<br />
products and latest development and trends<br />
Key Topics Covered in the Report
<strong>United</strong> <strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> Cases (2010 - <strong>2022</strong>)<br />
<strong>United</strong> <strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> Mammography <strong>Screening</strong> Population (2010 – <strong>2022</strong>)<br />
<strong>United</strong> <strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> Death (2010 – 2017)<br />
<strong>Market</strong> Overview: <strong>United</strong> <strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> (2010 – <strong>2022</strong>)<br />
<strong>Market</strong> Share: <strong>United</strong> <strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> (2010 – <strong>2022</strong>)<br />
By Types (Mammography, <strong>Breast</strong> MRI & <strong>Breast</strong> Ultrasound): <strong>Market</strong> Size & Analys<strong>is</strong> (2010 –<br />
<strong>2022</strong>)<br />
Reimbursement Policies of the <strong>United</strong> <strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong><br />
<strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> Clinical Trail Insight <strong>by</strong> Phase, Company & Country<br />
Key Drivers and Inhibi<strong>to</strong>rs of the <strong>United</strong> <strong>States</strong> <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong><br />
Key Manufacturers Analys<strong>is</strong><br />
Major <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> Analyzed Under Th<strong>is</strong> Report Are:<br />
Mammography<br />
<strong>Breast</strong> Magnetic Resonance Imaging(MRI)<br />
<strong>Breast</strong> Ultrasound<br />
Major Companies Covered in Th<strong>is</strong> Report:<br />
Hitachi Medical Corporation<br />
Siemen Healthineers<br />
Philips Healthcare<br />
Toshiba Medical Systems Corporation<br />
GE Healthcare<br />
Hologic<br />
Obtain Report Details: https://www.futuregenicreports.com/Reports/<strong>Breast</strong>-<strong>Cancer</strong>-<strong>Screening</strong>-<strong>Market</strong><br />
By Regional Analys<strong>is</strong>:<br />
Europe<br />
Asia Pacific<br />
Middle East and Africa (MEA)<br />
North America<br />
Latin America<br />
About Us<br />
Future Generic Reports <strong>is</strong> a market research and consulting organization, offering premium collection of<br />
market research reports, cus<strong>to</strong>m research and consulting services <strong>to</strong> corporations, no-profit organizations
and government institutions across the globe. The wide range of information <strong>is</strong> presented <strong>by</strong> a team of welltrained<br />
researchers of specific sec<strong>to</strong>rs through exhaustive research. We deliver premier market research<br />
services that cover all industry verticals, including chemicals and material, au<strong>to</strong>motive, healthcare,<br />
electronics & semiconduc<strong>to</strong>r, food and beverage, pharmaceuticals and technology and media.<br />
We believe in building an eternal bond with our clients through offering them inclusive research study<br />
meeting their specific requirements. Our services are tailored specifically <strong>to</strong> our clients <strong>by</strong> proposing them<br />
the potential outcome, based on our in-depth analys<strong>is</strong> and insights for exploring the growth strategies<br />
through providing the best possible dec<strong>is</strong>ion for quality production.<br />
Contact Us<br />
Future Generic Reports<br />
USA Office<br />
244 , Mad<strong>is</strong>on Avenue<br />
New York City, NY - 10016<br />
<strong>United</strong> <strong>States</strong><br />
UK Office<br />
109 ,Straford Street,Leeds<br />
West Yorkshrie LS11 6JG<br />
<strong>United</strong> Kingdom<br />
Toll Free +1- 844-445-2861<br />
Email : sales@futuregenicreports.com
Change language